G01

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

COXSACKIEVIRUS B4 STRAIN AND APPLICATION THEREOF
US 20250009867 A1Applicant: INST MED BIOLOGY CAMSPriority: 2023
CN
US
2 publications
POWDEROUS COMPOSITION COMPRISING CAROTENOID AND/OR DERIVATIVE THEREOF, D-GLYCOSE OLIGOMERS AND MODIFIED POLYSACCHARIDE AS WELL AS FOOD, FEED OR PERSONAL CARE FORMULATION COMPRISING THE COMPOSITION
CN 112105268 AApplicant: DSM IP ASSETS BVPriority: 2018
CN
POWDEROUS COMPOSITION COMPRISING CAROTENOID AND/OR DERIVATIVE THEREOF, D-GLYCOSE OLIGOMERE AND MODIFIED POLYSACCHARIDE AS WELL AS FOOD, FEED OR PERSONAL CARE FORMULATION COMPRISING THE COMPOSITION
CN 112040790 AApplicant: DSM IP ASSETS BVPriority: 2018
CN
Application of combination of emodin and imatinib in production of medicine for treating chronic myeloid leukemia
CN 110812361 AApplicant: UNIV CHINA PHARMAPriority: 2019
CN
一种利用重组谷氨酸棒杆菌发酵生产L-谷氨酸的方法
CN 111394291 BApplicant: 江南大学Priority: 2020
CN
一种用离子转运蛋白促进谷氨酸棒杆菌合成氨基酸的方法
CN 111718882 BApplicant: 江南大学Priority: 2020
CN
一种提高谷氨酸棒杆菌合成L-谷氨酸产量的方法
CN 113881611 BApplicant: 江南大学Priority: 2021
CN
一种促进耐伊马替尼慢性髓细胞白血病细胞K562/G01凋亡shRNA及其应用
CN 113528528 BApplicant: 南昌大学第二附属医院Priority: 2021
CN
Medicine capable of reversing resistance of chronic myelogenous leukemia to imatinib medicine
CN 114053275 AApplicant: XIANGYA HOSPITAL CENTRAL SOUTH UNIVPriority: 2021
CN
Drug-resistant pharmaceutical composition for resisting chronic myelogenous leukemia and application of drug-resistant pharmaceutical composition
CN 116942687 AApplicant: INTERNATIONAL PHYSICAL DIAGNOSIS RESEARCH INSTITUTE OF CHONGQING MEDICAL UNIVPriority: 2023
CN